6016

Shanghai Pharmaceuticals Holding Co., Ltd Stock Price

SHSE:601607 Community·CN¥60.4b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

601607 Share Price Performance

CN¥17.95
-3.95 (-18.04%)
CN¥17.95
-3.95 (-18.04%)
Price CN¥17.95

601607 Community Narratives

There are no narratives available yet.

Recent 601607 News & Updates

Here's What To Make Of Shanghai Pharmaceuticals Holding's (SHSE:601607) Decelerating Rates Of Return

Apr 01
Here's What To Make Of Shanghai Pharmaceuticals Holding's (SHSE:601607) Decelerating Rates Of Return

Shanghai Pharmaceuticals Holding Co., Ltd Key Details

CN¥277.4b

Revenue

CN¥248.1b

Cost of Revenue

CN¥29.3b

Gross Profit

CN¥23.2b

Other Expenses

CN¥6.1b

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Oct 31, 2025
Earnings per share (EPS)
1.64
Gross Margin
10.56%
Net Profit Margin
2.19%
Debt/Equity Ratio
66.6%

Shanghai Pharmaceuticals Holding Co., Ltd Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Undervalued with excellent balance sheet.

0 Risks
3 Rewards

About 601607

Founded
1994
Employees
50120
CEO
Bo Shen
WebsiteView website
www.sphchina.com

Shanghai Pharmaceuticals Holding Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical and healthcare products in China and internationally. It operates through four segments: Production, Distribution, Retail, and Others. The company offers chemical and biological drugs, Chinese medicine, health care products, and medical devices to treat immunology, psychiatric and neurological, tumor, cardiovascular, digestive metabolism, psychoneurotic, neoplasm, respiratory system, and anti-infection diseases, as well as invests in equity. It also engages in the provision of pharmaceutical distribution, warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, the company engages in the operation of a network of retail pharmacy stores. Shanghai Pharmaceuticals Holding Co., Ltd. was incorporated in 1994 and is headquartered in Shanghai, China.

Market Insight

Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading

Chinese Market Performance

  • 7 Days: 1.8%
  • 3 Months: 18.3%
  • 1 Year: 24.1%
  • Year to Date: 26.2%
Over the past 7 days, the market has risen 1.8% with the Industrials sector contributing the most to the gain. The market is up 24% over the last 12 months. Earnings are forecast to grow by 27% annually. Market details ›